CA2543794A1 - Novel multipotent stem cells and use thereof - Google Patents

Novel multipotent stem cells and use thereof Download PDF

Info

Publication number
CA2543794A1
CA2543794A1 CA002543794A CA2543794A CA2543794A1 CA 2543794 A1 CA2543794 A1 CA 2543794A1 CA 002543794 A CA002543794 A CA 002543794A CA 2543794 A CA2543794 A CA 2543794A CA 2543794 A1 CA2543794 A1 CA 2543794A1
Authority
CA
Canada
Prior art keywords
cells
bone marrow
cell
hbmsc
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002543794A
Other languages
English (en)
French (fr)
Inventor
Young-Sup Yoon
Douglas W. Losordo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Elizabeths Medical Center of Boston Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2543794A1 publication Critical patent/CA2543794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002543794A 2003-10-28 2004-10-28 Novel multipotent stem cells and use thereof Abandoned CA2543794A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51532003P 2003-10-28 2003-10-28
US60/515,320 2003-10-28
PCT/US2004/036298 WO2005042723A2 (en) 2003-10-28 2004-10-28 Novel multipotent stem cells and use thereof

Publications (1)

Publication Number Publication Date
CA2543794A1 true CA2543794A1 (en) 2005-05-12

Family

ID=34549391

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002543794A Abandoned CA2543794A1 (en) 2003-10-28 2004-10-28 Novel multipotent stem cells and use thereof

Country Status (7)

Country Link
EP (1) EP1685237A4 (de)
JP (1) JP2007519397A (de)
KR (1) KR20070007030A (de)
CN (1) CN101072867A (de)
AU (1) AU2004286322A1 (de)
CA (1) CA2543794A1 (de)
WO (1) WO2005042723A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115369077A (zh) * 2022-07-29 2022-11-22 佛山市中科律动生物科技有限公司 Meflc细胞株及其构建方法和应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047963A2 (en) * 2005-10-20 2007-04-26 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of bone-marrow derived stem cells to treat ischemia
US9155762B2 (en) 2005-12-08 2015-10-13 University Of Louisville Research Foundation, Inc. Uses and isolation of stem cells from bone marrow
WO2007067280A2 (en) * 2005-12-08 2007-06-14 University Of Louisville Research Foundation, Inc. Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
JP2009535347A (ja) * 2006-04-28 2009-10-01 テュレーン・ユニバーシティ・ヘルス・サイエンシーズ・センター 糖尿病の治療方法
WO2009042173A1 (en) * 2007-09-24 2009-04-02 University Of South Florida Materials and methods for treating allergic and inflammatory conditions
US20110135610A1 (en) * 2009-10-30 2011-06-09 The University Of North Carolina At Chapel Hill Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
US11312940B2 (en) 2015-08-31 2022-04-26 University Of Louisville Research Foundation, Inc. Progenitor cells and methods for preparing and using the same
WO2017152073A1 (en) 2016-03-04 2017-09-08 University Of Louisville Research Foundation, Inc. Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307195T1 (de) * 1997-07-14 2005-11-15 Osiris Therapeutics Inc Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
US6291240B1 (en) * 1998-01-29 2001-09-18 Advanced Tissue Sciences, Inc. Cells or tissues with increased protein factors and methods of making and using same
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115369077A (zh) * 2022-07-29 2022-11-22 佛山市中科律动生物科技有限公司 Meflc细胞株及其构建方法和应用

Also Published As

Publication number Publication date
KR20070007030A (ko) 2007-01-12
WO2005042723A2 (en) 2005-05-12
EP1685237A4 (de) 2007-12-26
CN101072867A (zh) 2007-11-14
JP2007519397A (ja) 2007-07-19
AU2004286322A1 (en) 2005-05-12
EP1685237A2 (de) 2006-08-02
WO2005042723A3 (en) 2007-03-29
WO2005042723A9 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
Yoon et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction
Poulsom et al. Adult stem cell plasticity
US20100267107A1 (en) Methods for isolating very small embryonic-like (vsel) stem cells
US20120021482A1 (en) Methods for isolating very small embryonic-like (vsel) stem cells
US8119123B2 (en) Compositions comprising vascular and myocyte progenitor cells and methods of their use
US8747905B2 (en) Therapeutic use of CD31 expressing cells
US20040126879A1 (en) Heart derived cells for cardiac repair
US9155762B2 (en) Uses and isolation of stem cells from bone marrow
HK1200866A1 (en) Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
JP2009524421A (ja) 脂肪組織由来細胞を培養する方法及びその使用
KR20110034617A (ko) 심장 조직을 처치하는 세포를 이용하는 조성물 및 방법
US20160030483A1 (en) Materials and methods for treating allergic and inflammatory conditions
WO2002075302A1 (en) Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
AU2004286322A1 (en) Novel multipotent stem cells and use thereof
US20070253937A1 (en) Novel multipotent stem cells and use thereof
Chen et al. Endothelial cells regulate cardiomyocyte development from embryonic stem cells
US20040071665A1 (en) Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
Shibuya et al. Tongue muscle-derived stem cells express connexin 43 and improve cardiac remodeling and survival after myocardial infarction in mice
US20090155220A1 (en) Use of Bone-Marrow Derived Stem Cells to Treat Ischemia
Emanueli et al. In search of the best candidate for regeneration of ischemic tissues
US20230256022A1 (en) C-kit-positive bone marrow cells and uses thereof
Vawda et al. Stem cells in neurodegeneration and injury
Iwasaki et al. Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction
Péault et al. Células tronco e desenvolvimento do músculo esquelético. Perspectivas para o tratamento do rabdomiosarcoma
Chen The role of human blood-vessel-derived stem cells in tissue repair and regeneration

Legal Events

Date Code Title Description
FZDE Discontinued